1[11]Gates LK Jr.Severity scoring for acute pancreatitis:where do we stand in 1999?Curr Gastroenterol Rep, 1999,1(2):134-138.
2[12]Imrie CW,McKay CJ.The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis.Baillieres Best Pract Res Clin Gastroenterol, 1999,13(2):357-364.
3[13]Buechler MW,Gloor B,Muller CA, et al.Acute necrotizing pancreatitis:treatment strategy according to the status of infection.Ann Surg, 2000,232(5):627-629.
4[14]Lundberg AH,Fukatsu K,Gaber L, et al.Blocking pulmonary ICAM-1 expression ameliorates lung injury in established diet-induced pancreatitis.Ann Surg, 2001,233(2):213-220.
5[15]Yoshinaga K,Washizuka M,Segawa Y.Fasting exacerbates acute pancreatitis by occlusion of the common bile duct in rats.Jpn J Pharmacol, 2000,84(4):455-461.
7[2]Wang Y,Naruse S,Kitagawa M, et al.Urinary exceretion of trypsinogen activation peptide(TAP)in taurocholate-induced pancreatitis in rats.Pancreas,2001,22(1):24-27.
8[3]Hedstrom J,Kemppainen E,Andersen J, et al.A comparison of serum trypsiongen-2 and trypsin-2-alphal-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis.Am J Gastroenterol, 2001,96(2):424-430.
9[4]Telek G,Ducroc R,Scoazec JY, et al.Differential upregulation of celluar adhesion molecules at the sites of oxidative stress in experimental acute pancreatitis.J Surg Res, 2001,96(1):56-67.
10[5]Rau B,Bauer A,Wang A, et al.Modulation of endogenous nitric oxide synthase in experimental acute pancreatitis:role of anti-ICAM-1 and oxygen free radical scavengers.Ann Surg, 2001,233(2):195-203.
